These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 331760)

  • 1. [Results of the study of preventive effectiveness and side effects of anti-influenza lactoglobulin in controlled epidemiologic trial].
    Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Salmin LV; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):109-14. PubMed ID: 331760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses.
    Aymard M; Bentejac MC; Larbaigt G; Michaut D; Triau R
    Dev Biol Stand; 1979; 43():231-9. PubMed ID: 520670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Pavlova LI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Belashev VP; Malinovskiĭ AA
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):40-3. PubMed ID: 9700880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic results of a committee trial of the new vaccine Grippovac SE-AZh].
    Bashliaeva ZA; Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Ozeretskovskaia NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):49-54. PubMed ID: 3515812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of influenza vaccines.
    Brenner E
    J S C Med Assoc; 2011 Jun; 107(3):78-82. PubMed ID: 22057708
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the basic parameters of killed influenza vaccine purified and concentrated on sodium borsilicate glass].
    Sumarokov AA; Agafonov VI; Perepelkin VS; Nefedova LA; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):22-7. PubMed ID: 797189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of live influenza vaccines. Its assessment in field and experimental conditions.
    Jovanovic D; Georges-Delvaux AM; Delem A
    Dev Biol Stand; 1979; 43():241-5. PubMed ID: 391630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and epidemiological aspects of influenza chemoprophylaxis with bonaphthone].
    Zykov MP; Zlydnikov DM; Romanov IuA; Shvetsova EG; Malysheva AM
    Vopr Virusol; 1975; (1):58-62. PubMed ID: 1092074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984].
    Chumakov MP; Boĭko VM; Malyshkina LP; Mel'nikova SK; Rodin VI
    Vopr Virusol; 1987; 32(2):175-83. PubMed ID: 3300032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of misclassification on evaluating the effectiveness of influenza vaccines.
    Ozasa K
    Vaccine; 2008 Nov; 26(50):6462-5. PubMed ID: 18573297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of a subunit influenza vaccine.
    Pyrhönen S; Suni J; Romo M
    Scand J Infect Dis; 1981; 13(2):95-9. PubMed ID: 7031855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sickness-like reaction after influenza vaccination.
    Chiong FJ; Loewenthal M; Boyle M; Attia J
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26677148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Five years experience with an influenza subunit vaccine (author's transl)].
    Majer M; Kindt H; Mettier B
    Immun Infekt; 1981 Nov; 9(6):232-8. PubMed ID: 7040211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine 2011-2012.
    Med Lett Drugs Ther; 2011 Oct; 53(1375):81-3. PubMed ID: 21996921
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems of large scale influenza vaccine trials.
    Smith JW
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):19-26. PubMed ID: 1206028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the reactivity, safety and immunogenicity of the polyvalent subunit "Grippovak SE-Azh" influenza vaccine in boarding houses for the elderly and disabled].
    Beregovskiĭ NA; Malyshkina LP; Serdiukova LP; Belousova NI; Velikiĭ VN
    Vestn Akad Med Nauk SSSR; 1985; (1):9-12. PubMed ID: 3156457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of live influenza vaccines in a controlled trial. 3. Evaluation of the epidemiological effectiveness of live influenza vaccines].
    Sumarokov AA; Popov VF; Nefedova LA; Salmin LV; Lazorenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Feb; 48(2):46-53. PubMed ID: 5581219
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection conferred by live influenza vaccines.
    Morris CA; Stealey VM; Hasell SK; Freestone DS
    Lancet; 1976 Dec; 2(7997):1244-5. PubMed ID: 63062
    [No Abstract]   [Full Text] [Related]  

  • 19. [The results of state trials of inactivated influenza vaccines for children].
    Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing influenza in healthy children.
    Jefferson T; Rivetti A; Harnden A; Di Pietrantonj C; Demicheli V
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004879. PubMed ID: 18425905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.